a public good project by the
Synthesis
Company
of California

© 2026

Catherine L. Day | doi.page

0 works0 citations0 h-index

Catherine L. Day

Pfizer (United States)(US)University of Otago(NZ)

Publications by Year

Research Areas

Ubiquitin and proteasome pathways, Cell death mechanisms and regulation, Cancer-related Molecular Pathways, RNA Interference and Gene Delivery, Infant Nutrition and Health

Most-Cited Works

→ Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function(2005)1,794 cited
→ The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized(2006)1,217 cited
→ HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins(2002)548 cited
→ Structural insights into the degradation of Mcl-1 induced by BH3 domains(2007)438 cited
→ Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans(2008)276 cited
→ The Bcl-2-regulated apoptotic pathway(2003)236 cited

→ TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis(2009)

231 cited

→ Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands(2004)228 cited

→ Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets(2006)215 cited

→ RINGs hold the key to ubiquitin transfer(2011)213 cited